Quick Takeaways
- PDSB - PDS Biotechnology Corp has 17 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 17 Insiders of PDS Biotechnology Corp
- Symbol
- PDSB on Nasdaq
- Location
- Princeton, NJ
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
PDS Biotechnology Corp executives and other stock owners filed with the SEC include:
Top shareholders of PDS Biotechnology Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DeLyle W. Bloomquist |
3/4/5
|
Resigned as a Director on June 17, 2021. |
—
mixed-class rows
|
804,941
mixed-class rows
|
$7,813,350 | — | 16 Jun 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.7%
|
2,834,506
|
$2,182,003 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
1,950,946
|
$1,502,228 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
522,211
|
$401,998 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
520,398
|
$400,666 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.51%
|
251,705
|
$193,812 | — | 31 Dec 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.5%
|
250,000
|
$192,450 | — | 31 Dec 2025 | |
| Seth van Voorhees |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
17,647
|
$172,588 | — | 15 Jun 2021 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.4%
|
196,797
|
$151,490 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.39%
|
192,556
|
$148,230 | — | 31 Dec 2025 | |
| INSPIRION WEALTH ADVISORS, LLC |
13F
|
Company |
0.36%
|
180,495
|
$138,945 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
176,700
|
$136,024 | — | 31 Dec 2025 | |
| Stephen C. Glover |
3/4/5
|
Director |
—
mixed-class rows
|
148,788
mixed-class rows
|
$130,893 | — | 12 Jan 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
143,873
|
$110,753 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
133,333
|
$102,640 | — | 31 Dec 2025 | |
| Gregory Gene Freitag |
3/4/5
|
Director |
—
mixed-class rows
|
131,149
mixed-class rows
|
$101,614 | — | 12 Jan 2026 | |
| Iron Gate Global Advisors LLC |
13F
|
Company |
0.15%
|
75,016
|
$57,747 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
69,311
|
$53,356 | — | 31 Dec 2025 | |
| Tempus Wealth Planning, LLC |
13F
|
Company |
0.12%
|
61,800
|
$47,574 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
38,566
|
$29,688 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
34,218
|
$26,341 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.06%
|
32,099
|
$25,000 | — | 31 Dec 2025 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
30,000
|
$23,094 | — | 31 Dec 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.05%
|
25,664
|
$19,756 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.04%
|
19,106
|
$14,711 | — | 31 Dec 2025 | |
| StoneX Group Inc. |
13F
|
Company |
0.03%
|
16,000
|
$12,317 | — | 31 Dec 2025 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.03%
|
15,000
|
$11,547 | — | 31 Dec 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.03%
|
14,800
|
$11,396 | — | 31 Dec 2025 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.03%
|
14,703
|
$11,318 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.03%
|
13,736
|
$10,574 | — | 31 Dec 2025 | |
| Wealth Group, Ltd. |
13F
|
Company |
0.03%
|
13,399
|
$10,000 | — | 31 Dec 2025 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.02%
|
10,000
|
$7,698 | — | 31 Dec 2025 | |
| GRANDFIELD & DODD, LLC |
13F
|
Company |
0.02%
|
10,000
|
$7,698 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
9,393
|
$7,231 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,329
|
$4,102 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,922
|
$3,789 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
3,922
|
$3,019 | — | 31 Dec 2025 | |
| CREATIVE FINANCIAL DESIGNS INC /ADV |
13F
|
Company |
0.01%
|
3,000
|
$2,309 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,220
|
$1,709 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
2,000
|
$1,538 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,028
|
$791 | — | 31 Dec 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
655
|
$504 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
648
|
$499 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
109
|
$84 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
19
|
$15 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
17
|
$13 | — | 31 Dec 2025 | |
| Frank Bedu-Addo |
3/4/5
|
President/CEO, Director |
—
class O/S missing
|
548,782
|
— | — | 12 Jan 2026 | |
| Kirk V Shepard |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
300,000
|
— | — | 12 Jan 2026 | |
| Lars Boesgaard |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
300,000
|
— | — | 12 Jan 2026 | |
| Spencer D. Brown |
3/4/5
|
Senior VP, General Counsel |
—
class O/S missing
|
300,000
|
— | — | 12 Jan 2026 |
Recent Insider Transactions by Companies or Individuals for PDS Biotechnology Corp
Showing up to 300 most recent insider transactions from the last 12 months.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.